ANL Adlai Nortye Ltd Bozor kapitallashuvining balans qiymatiga nisbati

ANL (Adlai Nortye Ltd) - kompaniyaning tovar belgisi

Adlai Nortye Ltd. (ANL) AQSh va Xitoyda qat'iy tartibga solish nazoratini amalga oshirish uchun o'z ishlanmalari uchun patent himoyasidan foydalanadi. Kompaniyaning ekologik strategiyasi laboratoriya chiqindilarini tozalash va yashil energiyaga o'tishga asoslangan. GURU.Markets platformasidagi ushbu narx jadvali, indikator 3.06 ga teng bo'lib, barqarorligi YaIM sikllari va mavsumiy tebranishlardan mustaqil bo'lib qoladigan aktivning narx harakatini aks ettiradi.

adlainortye.com (ANL) Kapitallashuvning balans qiymatiga nisbati: 21.02.2024 - 30.10.2026 davri uchun

Adlai Nortye Ltd. kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Aksiya narxi adlainortye.com|ANL - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Adlai Nortye Limited|ANL - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya uchun sof aktivlar Adlai Nortye|ANL - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati adlainortye.com|ANL - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Adlai Nortye Ltd.|ANL - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati adlainortye.com|ANL - Jamlangan qarz majburiyatlari|Qarzning balans qiymatiga nisbati Adlai Nortye Limited|ANL - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzlari Adlai Nortye|Tezkor likvidlik ko‘rsatkichi adlainortye.com
- foyda va bozor multiplikatorlari tafsilotlari:
ANL - Sof foyda
Kompaniyaning jamlanma tahliliyoti:Adlai Nortye Ltd, ANL
adlainortye.com yetakchi tovari

Kapital barqarorligi Adlai Nortye Ltd. uchun biotexnologiya sektorida juda muhimdir, chunki molekulalarni litsenziyalash FDA tasdig'ini olish uchun ulkan rezervlarni talab qiladi. Ushbu ko'rsatkich biznesning bozor qiymatini uning sof aktivlari bilan solishtiradi. Kompaniya qiymatining kitob kapitalizatsiyasiga nisbatdagi joriy koeffitsiyentini tahlil qilish orqali investor real resurslarning bozorda haddan tashqari qimmat baholanganligi yoki past baholanganligi darajasini aniqlaydi. Ushbu grafik biznesning operatsion risklar sharoitida premium qiymatni saqlab qolish qobiliyatini aks ettiradi, metrikaning pasayishi esa marjalarning qisqarishi ehtimolini bildiradi.

Adlai Nortye Ltd. kimlar bilan raqobatlashadi

ONC: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati halozyme.com|RVMD (Revolution Medicines, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Ascentage Pharma Group International|Bozor qiymatining balans qiymatiga nisbati CG Oncology Corp (CGON)|UroGen Pharma Corp - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati BCAX (Bicara Therapeutics Inc.)|PSNL - Kapitallashuvning sof aktivlarga nisbati|Erasca - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Delcath Systems Inc|YmAbs (YMAB) - Bozor qiymatining balans qiymatiga nisbati|Aura Corp - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati CADL|ARAY: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati SLS|Kapitallashuvning sof aktivlarga nisbati Actuate Therapeutics Inc. ACTU|Citius Oncology, Inc - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati TuHURA Biosciences Inc. HURA|TARA - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati FATE (fatetherapeutics.com)|WHWK: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti TScan Therapeutics, Inc. (TCRX)|CSBR (Champions Oncology Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati XBiotech USA|Bozor kapitallashuvining balans qiymatiga nisbati CVM|ostherapies.com - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Radiopharm Theranostics RADX|Artiva Biotherapeutics Inc. - Bozor qiymatining balans qiymatiga nisbati|Veru Pharma - Bozor kapitallashuvining balans qiymatiga nisbati|TPST - Bozor kapitallashuvining balans qiymatiga nisbati|XLO: Bozor kapitallashuvining balans qiymatiga nisbati|RENB - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati MURA|KAPA: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati OnKure Therapeutics Inc (OKUR)|w2.cytomed.sg - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Curis CRIS|Apollomics Inc. (APLM) - Bozor qiymatining balans qiymatiga koeffitsiyenti|THAR - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ADVB (Advanced Biomed Inc)|GNPX (Genprex, Inc) - Kapitallashuvning sof aktivlarga nisbati|CLDI: Bozor kapitallashuvining balans qiymatiga multiplikatori|Kapitallashuvning sof aktivlarga nisbati SBFM|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenetic Bio XBIO|Bozor kapitallashuvining balans qiymatiga nisbati SLRX|PPBT - Bozor qiymatining balans qiymatiga koeffitsiyenti|American Oncology Network, Inc. - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati BGNE|CKPT - Bozor qiymatining balans qiymatiga nisbati|ELEV: Bozor qiymatining balans qiymatiga nisbati|ICAD (icadmed.com) - Kapitallashuvning sof aktivlarga nisbati|IKNA: Bozor kapitallashuvining balans qiymatiga multiplikatori|NTBL (Notable Labs Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati VIRX (Viracta)|Kapitallashuvning sof aktivlarga nisbati MOR (MorphoSys AG)|Balans qiymatiga nisbatan bozor kapitallashuvi nayabiosciences.com|Bozor kapitallashuvining balans qiymatiga nisbati AAPGV (Ascentage Pharma)